Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Evelyn Ullrich, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, talks on the development of NK-CAR immunotherapy over the past 12 months and important routes for further study. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).